Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause temporary hair loss due to the body's immune response.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 may cause a common type of hair loss called telogen effluvium.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

More research is needed to understand sex and racial differences in long COVID.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 can cause temporary hair loss.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Rosemary oil and minoxidil 2% both effectively increase hair count in people with androgenetic alopecia, but rosemary oil causes less scalp itching.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Platelet-derived products help regenerate tissue and are used in various skin and hair treatments.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Proper hygiene, adequate sleep, and self-care can reduce common skin diseases.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.